高雄醫學大學圖書館 |

Non-alcoholic fatty liver diseasea 360-degree overview /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Non-alcoholic fatty liver disease/ edited by Elisabetta Bugianesi.
Reminder of title:	a 360-degree overview /
other author:	Bugianesi, Elisabetta.
Published:	Cham :Springer International Publishing : : 2020.,
Description:	x, 362 p. :ill., digital ; : 24 cm.;
基督教聖經之智慧書導讀 :	The goal of this book is to promote awareness of non-alcoholic fatty liver disease (NAFLD) - which is rapidly replacing viral hepatitis as the leading cause of chronic liver disease in Europe, North and South America and Asia - and to share the latest information on evolving approaches to diagnosis and treatment. The book offers a comprehensive overview of the current topics of interest in the field, and provides clinical guidance on NAFLD through a multidisciplinary approach based on the latest scientific understanding of this multisystemic disease, involving the expertise of specialists including hepatologists, diabetologists, and cardiologists. The respective contributions address various aspects, including the newly released international guidelines, novel diagnostic modalities, and new experimental drugs. The work will appeal to a broad readership, from residents in internal medicine to specialists.
Contained By:	Springer Nature eBook
Subject:	Cardiology. -
Online resource:	https://doi.org/10.1007/978-3-319-95828-6
ISBN:	9783319958286

Non-alcoholic fatty liver diseasea 360-degree overview /
Non-alcoholic fatty liver diseasea 360-degree overview /[electronic resource] :edited by Elisabetta Bugianesi. - Cham :Springer International Publishing :2020. - x, 362 p. :ill., digital ;24 cm.

Introduction -- Obesity and NAFLD: same problem? The burden of NAFLD worldwide -- Histo-pathology of NAFLD -- NAFLD and insulin resistance: a multisystemic -- Etiopathogenesis of NAFLD: diet, gut and NASH -- Etiopathogenesis of NAFLD: molecular mechanisms of fibrogenesis -- The natural history of NAFLD: Environmental vs Genetic Risk Factors -- NAFLD and endocrine disease: clinical implications -- NAFLD and Cardiovascular Disease: clinical implications -- NAFLD, Hepatocellular Carcinoma and extrahepatic cancers -- NAFLD in children: implications for the future -- Diagnostic algorithm for the identification of NAFLD in primary care -- Non-Invasive diagnostic approach to NASH: Biological Markers -- Non-Invasive diagnostic approach to NASH: Radiological Diagnostics -- Dietary approach to NAFLD -- Physical Activity in NAFLD: what and how much? Pharmacological Therapy of NASH -- Bariatric Surgery and NASH: a feasible option? Liver transplantation and NASH -- Unmet needs and future goals.

The goal of this book is to promote awareness of non-alcoholic fatty liver disease (NAFLD) - which is rapidly replacing viral hepatitis as the leading cause of chronic liver disease in Europe, North and South America and Asia - and to share the latest information on evolving approaches to diagnosis and treatment. The book offers a comprehensive overview of the current topics of interest in the field, and provides clinical guidance on NAFLD through a multidisciplinary approach based on the latest scientific understanding of this multisystemic disease, involving the expertise of specialists including hepatologists, diabetologists, and cardiologists. The respective contributions address various aspects, including the newly released international guidelines, novel diagnostic modalities, and new experimental drugs. The work will appeal to a broad readership, from residents in internal medicine to specialists.

ISBN: 9783319958286

Standard No.: 10.1007/978-3-319-95828-6doiSubjects--Topical Terms:

217407
Cardiology.

LC Class. No.: RC848.F3 / N66 2020

Dewey Class. No.: 616.362

Non-alcoholic fatty liver diseasea 360-degree overview /
LDR:02894nam a2200325 a 4500 001 338331
003 DE-He213
005 20210128155848.0
006 m d
007 cr nn 008maaau
008 210622s2020 sz s 0 eng d
020 $a 9783319958286 $q (electronic bk.)
020 $a 9783319958279 $q (paper)
024 7 $a 10.1007/978-3-319-95828-6 $2 doi
035 $a 978-3-319-95828-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC848.F3 $b N66 2020
072 7 $a MJJ $2 bicssc
072 7 $a MED031000 $2 bisacsh
072 7 $a MJJ $2 thema
082 0 4 $a 616.362 $2 23
090 $a RC848.F3 $b N812 2020
245 0 0 $a Non-alcoholic fatty liver disease $h [electronic resource] : $b a 360-degree overview / $c edited by Elisabetta Bugianesi.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a x, 362 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction -- Obesity and NAFLD: same problem? The burden of NAFLD worldwide -- Histo-pathology of NAFLD -- NAFLD and insulin resistance: a multisystemic -- Etiopathogenesis of NAFLD: diet, gut and NASH -- Etiopathogenesis of NAFLD: molecular mechanisms of fibrogenesis -- The natural history of NAFLD: Environmental vs Genetic Risk Factors -- NAFLD and endocrine disease: clinical implications -- NAFLD and Cardiovascular Disease: clinical implications -- NAFLD, Hepatocellular Carcinoma and extrahepatic cancers -- NAFLD in children: implications for the future -- Diagnostic algorithm for the identification of NAFLD in primary care -- Non-Invasive diagnostic approach to NASH: Biological Markers -- Non-Invasive diagnostic approach to NASH: Radiological Diagnostics -- Dietary approach to NAFLD -- Physical Activity in NAFLD: what and how much? Pharmacological Therapy of NASH -- Bariatric Surgery and NASH: a feasible option? Liver transplantation and NASH -- Unmet needs and future goals.
520 $a The goal of this book is to promote awareness of non-alcoholic fatty liver disease (NAFLD) - which is rapidly replacing viral hepatitis as the leading cause of chronic liver disease in Europe, North and South America and Asia - and to share the latest information on evolving approaches to diagnosis and treatment. The book offers a comprehensive overview of the current topics of interest in the field, and provides clinical guidance on NAFLD through a multidisciplinary approach based on the latest scientific understanding of this multisystemic disease, involving the expertise of specialists including hepatologists, diabetologists, and cardiologists. The respective contributions address various aspects, including the newly released international guidelines, novel diagnostic modalities, and new experimental drugs. The work will appeal to a broad readership, from residents in internal medicine to specialists.
650 0 $2 96060 $a Cardiology. $3 217407
650 0 $2 96060 $a Endocrinology. $3 187291
650 0 $a Hepatology. $3 464940
650 0 $a Fatty liver. $3 466291
700 1 $a Bugianesi, Elisabetta. $3 466290
710 2 $2 97100 $a SpringerLink (Online service) $3 255133
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-319-95828-6
950 $a Medicine (SpringerNature-11650)